期刊文献+

巨块型ⅠB、ⅡA期宫颈癌术前放化疗224例临床分析 被引量:2

The efficacy of preoperative chemoradiation for 224 cases of bulky stage ⅠB、ⅡA cervical cancer
下载PDF
导出
摘要 目的:探讨新辅助化疗对巨块型ⅠB、ⅡA期宫颈癌的近期疗效和预后影响。方法:回顾性分析了224例新辅助化疗配合腔内后装放疗(治疗组)及100例单独腔内后装放疗(对照组)后再行手术的巨块型ⅠB、ⅡA期宫颈癌的近期疗效和远期疗效。结果:对照组总有效率84.0%,5年生存率60.0%;治疗组总有效率91.1%,5年生存率为68.0%,两组总有效率和5年生存率的差异显著(P<0.05)。治疗组中新辅助化疗的方案对近期疗效无影响(P>0.05)。结论:巨块型ⅠB、ⅡA期宫颈癌术前行新辅助化疗配合腔内后装放射治疗,可能是更好的治疗选择。 Objective:To explore the efficacy of neoadjuvant chemotherapy(NAC) in bulky stage ⅠB and stage ⅡA cervical cancer.Methods:We retrospectively analyzed 224 cases of bulky stage ⅠB and stage ⅡA cervical cancer patients(treatment group) who received NAC and after-loading radiotherapy before operation,and 100 patients(control group) who received after-loading radiotherapy only before operation.Results:NAC combined with after-loading radiotherapy can achieve higher total effective rate(91.1%) and 5-year survival rate(68.0%) than those(84.0%,60.0%) of after-loading radiotherapy only before operation(P〈0.05).The regimen of NAC has no influence on the effective rate in our study(P〉0.05).Conclusion:The bulky stage ⅠB and stage ⅡA cervical cancer patients received NAC and after-loading radiotherapy before operation was an effective selection.
出处 《临床肿瘤学杂志》 CAS 2008年第10期911-913,共3页 Chinese Clinical Oncology
关键词 宫颈癌 新辅助化疗 后装放疗 Cervical cancer Neoadjuvant chemotherapy(NAC) After-loading radiotherapy
  • 相关文献

参考文献8

  • 1Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage I b cervical carcinoma[J]. N Engl J Med, 1999, 340: 1154-1161.
  • 2Termrungruanglert W, Tresukosol D, Vasuratna A, et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage I B2[JJ. Gynecol Oncol, 2005, 97:576-581.
  • 3Rose PG. Combined modality therapy of locally advanced cervical cancer[J]. J Clin Oncol, 2003, 21:211 -217.
  • 4Stewart LA, Tierney JF. Neoadjuvant chemotherapy and surgery versus standard radiotherapy for locally advanced cervix cancer: a meta analysis using individual patients data from randomized controlled trials (abstract) [ J ]. Proc Am Soc Clin Oncol, 2002, 21 : 207.
  • 5Sardi JE, Giaroli A, Sananes C, et al. Longterm follow up of the first randomized trial using neoadjuvant chemotherapy instage I b squamous carcinoma of the cervix: the final results[ J]. Gynecol Oncol, 1997, 67:61 -69.
  • 6Antonella S, Francesco C. New drugs in the treatment of recurrent or metastatic cervical cancer [ J]. Oncology/Hematology, 2003, 48 (30) : 323 -327.
  • 7陈明晖,巫岳鹏.宫颈癌化疗临床研究新进展[J].中国妇幼保健,2005,20(9):1150-1154. 被引量:6
  • 8Tierney J. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta2analysis of individual patient data from 21 randomised trial[ J]. Eur J Cancer, 2003, 39 : 2470 - 2486.

二级参考文献33

  • 1Tsuda H, Tanaka M, Manabe T et al. Phase Ⅰ - Ⅱ study of neoadjuvant chemoradiotherapy followed by radical surgery in locally advanced cervical cancer. Anticancer Drugs, 2001, 12 (10) : 853 -858.
  • 2Onishi H, Yamaguchi M, Kuriyama K et al. Effect of concurrent intraarterial infusion of platinum drugs for patients with stage HI or Ⅳ uterine cervical cancer treated with radical radiation therapy. Cancer J Sci Am, 2000, 6 (1): 40-45.
  • 3Lukka H, Hirte H, Fyles A et al. Concurrent cisplatin based chemotherapy plus radiotherapy for cervical cancer a meta analysis. Clin Oncol ( R Coll Radiol), 2002, 14 (3): 203-212.
  • 4Omura GA, Blessing JA, Vaccarello Let al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin ifosfamide in advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Groupstudy. J Clin Oncol, 1997, 15:165~171.
  • 5Bloss JD, Blessing JA, Behrens BC et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol, 2002, 20(7) : 1832 ~ 1837.
  • 6Rocio Garcia - Carbonero, Jefferey G, Supkel et al. Current perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins. Clincal Cancer Research, 2002, (8) :641 -661.
  • 7Lhomme C, Fumoleau P, Fargeot Pet al. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase Ⅱ trial of first line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix. J Clin Oncol, 1999,17 (10) : 3136 -3142.
  • 8Look KY, Blessing JA, Levenback C et al. A phaseⅡ trim of CPT - 11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol, 1998, 70 (3) : 334-338.
  • 9Suntompong N, Pattaranutapom p, Chanslip Y et al. Concurrent radiation therapy and irinotecan in stage IIIB cervical cancer. J Med Assoc Thai, 2003, 86 (5) : 430 -435.
  • 10Muderspach LI, Blessing JA, Levenback C et al. A Phase Ⅱ study of topotecan in patients with squamous cell carcinoma of the cervix : a gynecologic oncology group study. Gynecol Oncol, 2001, 81 (2) : 213-215.

共引文献5

同被引文献17

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2白惠娟,李秀荣,陈红敏.新辅助化疗治疗巨块型宫颈癌疗效观察[J].中国肿瘤临床与康复,2005,12(4):367-367. 被引量:6
  • 3Toita T, Mitsuhashi N, Teshirna T, et al. Postoperative radiotherapy for uterine cervical cancer: results of the 1995- 1997 patterns of care process survey in lapan[J]. Clin Oncol, 2004,34 (2) : 99-103.
  • 4Rutledge TL, Kamelle SA, Tillmanns TD, et al. A com- parison of stage Ⅰ b1 and Ⅰ b2 cervical cancers treated with radical hysterectomy: is size the real difference[J]. Gyneeol Oncol, 2004,95 (1) : 70-76.
  • 5Havrilesky LJ, Leath CA, Huh W, et al. Radical hyster- ectomy and pelvic lymphadenectomy for stage I b2 cervical cancer[J]. Gynecol Oncol,2004,93(2):429-434.
  • 6FIGO Committee on Gynecology Oneology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium [J]. Int J Gynecol Obstet, 2009,105 (2) : 103-104.
  • 7Cai HB,Chen HZ, Yin HH. Randomized study of preopera- tive chemotherapy versus primary surgery for stage Ⅰ b cervi- cal caneer[J]. J Obstet Gynecol Res, 2006,32(3) : 315-323.
  • 8Sardi JE, Boixadera MA, Sardi JJ. Neoadjuvant chemotherapy in cervical cancer:a new trend[J]. Curt Opin Obstet Cynecol, 2005,17(1) :43-47.
  • 9熊樱,粱立治,郑敏,王銮红,邓鹏飞,刘继红.子宫颈癌伴盆腔淋巴结转移患者的复发及预后分析[J].中华妇产科杂志,2008,43(6):425-428. 被引量:17
  • 10冯文,房瑜,黎群,蔡明,杨成喜.术前新辅助化疗治疗局部中晚期宫颈癌的临床初步观察[J].肿瘤基础与临床,2008,21(6):492-494. 被引量:4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部